General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities        
Net loss $ (46,560) $ (14,716) $ (32,504) $ (32,319)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 3,540 2,596 5,546 10,214
Loss on disposal of property and equipment     705 2,372
Stock-based compensation 4,501 920 2,160 1,890
Accretion on carrying value of convertible notes 3,302 2,193 4,490 1,454
Amortization of debt issuance costs 1,544 84 338 102
Change in fair value of warrant liability 10,176   198 0
Deferred income tax liabilities (23) 193 133 6
Loss on extinguishment of debt 2,277   171 0
Other       139
Changes in operating assets and liabilities:        
Accounts receivable (1,635) (607) (429) (134)
Contract assets and deferred contract costs     (1,057) (493)
Contract assets   (89)    
Other current assets (1,044) (87) 400 (1,209)
Other long-term assets 151   (152) 72
Accounts payable 1,133 756 1,106 (1,006)
Accrued wages and benefits 153 126 987 (48)
Contract liabilities 2,862 5,360 3,159 863
Other accrued expenses 456 491 493 771
Other long-term liabilities 1,016 (52) (517) 271
Net cash used in operating activities (18,151) (2,832) (14,773) (17,055)
Cash flows from investing activities        
Purchase of property and equipment (5,581) (6,766) (10,314) (9,344)
Investment in intangible assets (2)   (101) (73)
Net cash used in investing activities (5,583) (6,766) (10,415) (9,417)
Cash flows from financing activities        
Proceeds from long-term debt 70,000 1,709 30,937 0
Payments on long-term debt     (14,130) (1,500)
Proceeds from issuance of convertible notes payable 20,000 225 550 42,334
Payments on redemption of long-term debt (29,628) (3,000)    
Payment of debt issuance costs (4,274)   (808) (392)
Proceeds from exercise of stock options 673 2 75 46
Net cash provided by (used in) financing activities 56,771 (1,064) 16,624 40,488
Effect of foreign currency translation on cash, cash equivalent and restricted cash 403 318 19 (655)
Net increase (decrease) in cash, cash equivalents and restricted cash 33,440 (10,344) (8,545) 13,361
Cash, cash equivalents and restricted cash        
Beginning of period 15,986 24,531 24,531 11,170
End of period 49,426 14,187 15,986 24,531
Supplemental disclosure of cash flow information        
Cash paid for interest 676 $ 584 1,501 1,734
Cash paid for income taxes 233   0 59
Noncash Investing and financing activities        
Issuance of shares to FP (Note 6) 8,065      
Capitalized merger costs not yet paid 2,203      
Exercise of Series C preferred stock warrants 891      
Property and equipment purchased but not yet paid     18  
Issuance of stock warrants with long-term debt $ 308   $ 4,154 $ 0